Sage Journals: Discover world-class research

Abstract

A quality management system (QMS) is an integrated framework through which organizations can systematically plan and achieve their quality objectives. While the International Conference on Harmonisation (ICH) Q10 provides clear guidance for QMS in the pharmaceutical manufacturing sector, there is no harmonized regulatory guidance describing a framework that provides an enterprise-wide view of achievement of clinical quality objectives, that is capable of being customized to fit an organization’s unique circumstances, and that accommodates the variability inherent in clinical development. In the absence of such guidance, clinical QMS varies dramatically across industry, sometimes resulting in over-engineered, cumbersome systems that are not adaptable or fit-for-purpose. This paper will describe the ongoing activities of a TransCelerate initiative developing a conceptual framework for a Clinical QMS designed to provide a consistent, streamlined, and proactive quality approach across all stages of clinical research.

Keywords

quality management system clinical development risk management proactive quality

Get full access to this article

View all access options for this article.

References

Forbes Insights. Culture of quality: accelerating grown and performance in the enterprise. http://www.forbes.com/forbesinsights/asq/index.html. Accessed April 8, 2015.

International Conference on Harmonisation (ICH). ICH Harmonised Tripartite Guideline: Pharmaceutical Quality System Q10 (current step 4 version). June 4, 2008.

Woodcock

. Quality risk management in clinical trials. Expert meeting presentation at: Developing Effective Quality Systems in Clinical Trials: An Enlightened Approach. A Clinical Trials Transformation Initiative (CTTI)-Sponsored Meeting; October 13-14, 2010; Bethesda, MD.

Kleppinger

Ball

. Building quality in clinical trials with use of a quality systems approach. Clin Infect Dis. 2010;51(S1): S111–S116.

Medicines and Healthcare Products Regulatory Agency (MHRA). Quality systems [chapter 14]. In: MHRA. Good Clinical Practice Guide. London: MHRA; 2012:440–441.

Food and Drug Administration (FDA). Guidance for Industry: Oversight of Clinical Investigations—A Risk-Based Approach to Monitoring. Silver Spring, MD: FDA; 2013.

European Medicines Agency (EMA). Reflection Paper on Risk Based Quality Management in Clinical Trials. London: EMA; 2013.

Clinical Trials Transformation Initiative (CTTI). CTTI recommendations: effective and efficient monitoring as a component of quality assurance in the conduct of clinical trials. Durham, NC: CTTI; 2011.

International Organization for Standardization, ISO 9001: 2015, Quality Management Systems. http://www.iso.org/iso/iso9001_revision. Accessed April 22, 2015.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB